Details for 2020755296
Up to date per 01.04.2026
Actions
Details for 2020755296
Granted/Registered
European Patent
22.12.2021 A
31.07.2024 B1
12.02.2019
US
201962804523 P
20.06.2019
US
201962863904 P
30.09.2019
US
201962908431 P
07.11.2019
US
201962932015 P
A61K 31/4995 20060101AFI20231120BHEP
Owner
Mirum Pharmaceuticals, Inc.989 E Hillsdale Blvd., Suite 300 Foster City, CA 94404US
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
JAECKLIN, Thomas1, rue du Jura 2800 DelemontCH
DORENBAUM, Alejandro120 Stanford Avenue Mill Valley, CA 94941US
Information about Fees